Braidwell’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.5M Sell
596,900
-250,251
-30% -$7.35M 0.76% 53
2026
Q1
$26.2M Sell
847,151
-80,373
-9% -$1.98M 0.87% 46
2025
Q4
$19.3M Buy
927,524
+190,657
+26% +$3.54M 0.62% 54
2025
Q3
$11.6M Buy
+736,867
New +$15.2M 0.34% 62

Other funds holding TECX

Braidwell's TECX Position: Q2 2026 in Review

Braidwell reduced its Tectonic Therapeutic (TECX) stake by 30% in Q2 2026, selling an estimated $7.35M and leaving 596,900 shares worth $20.5M. The position accounts for 0.76% of the portfolio, ranked #53.

Braidwell first reported a position in TECX in Q3 2025 and has held it in 4 quarters since. The position peaked at $26.2M in Q1 2026. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Braidwell held 596,900 shares of Tectonic Therapeutic worth $20.5M as of Q2 2026.
  • Braidwell sold 250,251 Tectonic Therapeutic shares in Q2 2026, an estimated $7.35M.
  • Tectonic Therapeutic made up 0.76% of Braidwell's portfolio in Q2 2026, its #53 holding.
  • Braidwell first reported a position in Tectonic Therapeutic in Q3 2025 and has held it in 4 quarters since.
  • Braidwell's Tectonic Therapeutic position peaked at $26.2M in Q1 2026.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.